logo

Knowledge Management Series for Health 2026

Download Report (PDF | 1017.73 KB)

Lessons from South Sudan’s Post-Introduction Evaluation of PCV and Rotavirus Vaccine

In May 2025, South Sudan introduced the Pneumococcal Conjugate Vaccine (PCV) and Rotavirus Vaccine into the national routine immunization program, adding protection against two of the leading causes of childhood illness and death. Together, these vaccines provide a powerful “double shield” against pneumonia and severe diarrhoeal disease, conditions that continue to contribute substantially to under-five morbidity and mortality.

Beyond protecting children from disease, the introduction of PCV and rotavirus vaccine represented an important opportunity to strengthen routine immunization services, improve service integration, and expand access to lifesaving interventions during the first year of life. By introducing both vaccines through the infant immunization platform, South Sudan sought to ensure that children could benefit from multiple preventive interventions during the same visit while strengthening the overall immunization system.

To assess how effectively the vaccines were integrated into routine immunization services, the Ministry of Health conducted a Post-Introduction Evaluation (PIE) with support from WHO, UNICEF, Gavi, and immunization partners. The evaluation examined implementation performance, operational challenges, and early program outcomes, generating important lessons for sustaining vaccine delivery and improving immunization services nationwide.

The evaluation demonstrates that successful vaccine introduction is not only about adding new antigens to the schedule, but also about ensuring that the systems needed to deliver them reliably are strong enough to translate availability into protection.

Between May and November 2025, South Sudan conducted a nationwide PCV catch-up campaign targeting children aged 12–59 months. The campaign reached more than 2.2 million children and achieved approximately 88% administrative coverage, while post-campaign assessments documented over 83% coverage by vaccination card based on the post-campaign assessment. The results demonstrated the program’s ability to expand protection against pneumococcal disease rapidly and provided an important foundation for introducing PCV into routine immunization services.

Source: https://reliefweb.int/report/south-sudan/knowledge-management-series-health-2026-double-shield-first-year-life-november-2026